4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0000919574-19-003860
Director bought 29,000 shares at an average $5.02 ($145,539)
From the SEC's structured data for this filing
Trades in this filing
ARMISTICE CAPITAL, LLC · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-23 | Purchase : show line 1 in the form | +14,100 | $5.05 | $71,205 | 18,348,385 | D |
| 2019-05-23 | Purchase : show line 2 in the form | +0 | 18,348,385 | I | ||
| 2019-05-24 | Purchase : show line 3 in the form | +11,400 | $5.01 | $57,114 | 18,359,785 | D |
| 2019-05-24 | Purchase : show line 4 in the form | +0 | 18,359,785 | I | ||
| 2019-05-28 | Purchase : show line 5 in the form | +3,500 | $4.92 | $17,220 | 18,363,285 | D |
| 2019-05-28 | Purchase : show line 6 in the form | +0 | 18,363,285 | I | ||
| Open-market purchases · 29,000 sh · avg $5.02 · $145,539 | ||||||
Loading xslF345X03/ownership.xml…